[go: up one dir, main page]

NO970020D0 - Immunmodulatorer - Google Patents

Immunmodulatorer

Info

Publication number
NO970020D0
NO970020D0 NO970020A NO970020A NO970020D0 NO 970020 D0 NO970020 D0 NO 970020D0 NO 970020 A NO970020 A NO 970020A NO 970020 A NO970020 A NO 970020A NO 970020 D0 NO970020 D0 NO 970020D0
Authority
NO
Norway
Prior art keywords
immunomodulators
Prior art date
Application number
NO970020A
Other languages
English (en)
Other versions
NO970020L (no
Inventor
Larsen Christian Groenhoej
Borbala Gesser
Original Assignee
Steeno Res Group As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Steeno Res Group As filed Critical Steeno Res Group As
Publication of NO970020D0 publication Critical patent/NO970020D0/no
Publication of NO970020L publication Critical patent/NO970020L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5428—IL-10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO970020A 1994-07-05 1997-01-03 Immunmodulatorer NO970020L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK80094 1994-07-05
PCT/DK1995/000227 WO1996001318A1 (en) 1994-07-05 1995-06-07 Immunomodulators

Publications (2)

Publication Number Publication Date
NO970020D0 true NO970020D0 (no) 1997-01-03
NO970020L NO970020L (no) 1997-03-05

Family

ID=8097707

Family Applications (1)

Application Number Title Priority Date Filing Date
NO970020A NO970020L (no) 1994-07-05 1997-01-03 Immunmodulatorer

Country Status (27)

Country Link
US (3) US6159937A (no)
EP (2) EP1013764A1 (no)
JP (1) JPH10502249A (no)
CN (1) CN1216992C (no)
AP (1) AP690A (no)
AT (1) ATE195003T1 (no)
AU (1) AU686816B2 (no)
BR (1) BR9508243A (no)
CA (1) CA2194444C (no)
CZ (1) CZ1497A3 (no)
DE (1) DE69518156T2 (no)
DK (1) DK0769054T3 (no)
EE (1) EE03451B1 (no)
ES (1) ES2148525T3 (no)
FI (1) FI970009A7 (no)
GR (1) GR3034628T3 (no)
HU (1) HU220344B (no)
MX (1) MX9606537A (no)
NO (1) NO970020L (no)
NZ (1) NZ287406A (no)
PL (1) PL181042B1 (no)
PT (1) PT769054E (no)
RO (1) RO118758B1 (no)
RU (1) RU2218348C2 (no)
SK (1) SK283096B6 (no)
UA (1) UA57702C2 (no)
WO (1) WO1996001318A1 (no)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9403526D0 (sv) 1994-10-14 1994-10-14 Astra Ab New Peptides
SE9501067D0 (sv) 1995-03-24 1995-03-24 Astra Ab New peptides
WO1997026278A1 (en) * 1996-01-18 1997-07-24 Steeno Research Group A/S Synthetic il-10 analogues
US20030124125A1 (en) * 1996-04-05 2003-07-03 South Alabama Medical Science Foundation Oncofetal antigen specific T-lymphocyte mediated immune response: manipulation and uses of oncofetal antigen specific CD4, CD8 cytotoxic and suppressor T cells and interleukin-10
EP0906117A1 (en) * 1996-05-02 1999-04-07 Schering Corporation Method for treating or preventing ischemia-reperfusion injury
FR2748938B1 (fr) * 1996-05-22 1998-07-31 Pasteur Institut Utilisation de molecules antagonistes de chemokines pour leur activite antivirale notamment contre un retrovirus de type vih
SE9603463D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603468D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
US6086868A (en) * 1997-04-30 2000-07-11 Schering Corporation Method for treating or preventing ischemia-reperfusion injury
AU9449398A (en) * 1997-10-10 1999-05-03 Imperial College Innovations Ltd. Use of csaidtm compounds for the management of uterine contractions
US6685931B1 (en) * 1998-12-22 2004-02-03 Schering Corporation Treatment of hepatitis C virus infections with interleukin-10
AU5155700A (en) * 1999-05-25 2000-12-12 Canji, Inc. Gene therapy of pulmonary disease
JP3871503B2 (ja) * 1999-08-30 2007-01-24 日本たばこ産業株式会社 免疫性疾患治療剤
US20020183271A1 (en) * 2000-12-07 2002-12-05 Sunil Chada Methods of treatment involving human MDA-7
WO2002057283A1 (en) * 2001-01-19 2002-07-25 Baylor College Of Medecine Methods and compositions in breast cancer diagnosis and therapeutics
US20040086896A1 (en) * 2001-04-19 2004-05-06 Julie Carman Polynucleotides and polypeptides associated with the NF-kB pathway
BR0307691A (pt) * 2002-02-11 2005-01-11 Arkion Life Sciences Composição, fator de inibição de citocina purificado e seu método de purificação, método de inibição da expressão de citocina e método para modular o sistema imunológico de um animal
AU2003228267A1 (en) * 2002-03-05 2003-09-22 Board Of Regents, The University Of Texas System Methods of enhancing immune induction involving mda-7
RU2218347C2 (ru) * 2002-09-17 2003-12-10 Энтофарм Ко. Лтд Способ получения тридекапептида и пентапептид для его получения
RU2222543C2 (ru) * 2002-09-17 2004-01-27 Энтофарм Ко. Лтд. Способ получения тридекапептида
EP1444989A1 (en) * 2003-02-07 2004-08-11 Giorgio Dr. Stassi Sensitizing cells for apoptosis by selectively blocking cytokines
DK1628530T3 (da) * 2003-05-15 2012-07-23 Genentech Inc Fremgangsmåder og sammensætninger til forebyggelse og behandling af sepsis
US7261882B2 (en) 2003-06-23 2007-08-28 Reagents Of The University Of Colorado Methods for treating neuropathic pain by administering IL-10 polypeptides
US20050164244A1 (en) * 2003-10-23 2005-07-28 David Glass Methods of determining juvenile arthritis classification
CA2548220A1 (en) * 2003-12-01 2005-09-09 Introgen Therapeutics, Inc. Use of mda-7 to inhibit infection by pathogenic organisms
WO2005087793A2 (en) * 2004-02-05 2005-09-22 The Arizona Board Of Regents, A Body Corporate Acting On Behalf Of Arizona State University Immunostimulatory compositions and uses thereof
US20070281041A1 (en) * 2004-03-02 2007-12-06 Introgen Therapeutics, Inc. Compositions and Methods Involving MDA-7 for the Treatment of Cancer
CU23472A1 (es) * 2004-09-17 2009-12-17 Ct Ingenieria Genetica Biotech Péptido antagonista de la interleucina-15
WO2006063028A2 (en) * 2004-12-07 2006-06-15 The Arizona Board Of Regents, A Body Corporate Acting On Behalf Of Arizona State University Immunostimulatory compositions and uses thereof
GB0500643D0 (en) * 2005-01-13 2005-02-23 Renovo Ltd Medicaments
US20070009484A1 (en) * 2005-02-08 2007-01-11 Board Of Regents, The University Of Texas System Compositions and methods involving MDA-7 for the treatment of cancer
US20100028296A1 (en) * 2005-05-02 2010-02-04 Chavez Raymond A Use of cytokine-derived peptides in treatment of pain and neurodegenerative disease
US8114964B2 (en) * 2005-05-19 2012-02-14 Centocor, Inc. Anti-MCP-1 antibodies, compositions, methods and uses
EP1885863B1 (en) 2005-05-31 2014-11-19 The Regents of the University of Colorado, a body corporate Methods for delivering genes
RU2009101783A (ru) * 2006-06-21 2010-07-27 Апогеникс Гмбх (De) Дифференциальная экспрессия цитокинов il-4 и/или il-10 в злокачественной опухоли человека
CA2656135A1 (en) * 2006-07-06 2008-01-10 Apogenix Gmbh Human il-4 muteins in cancer therapy
USRE46425E1 (en) 2006-12-13 2017-06-06 Susavion Biosciences, Inc. Pro-angiogenic peptides and uses thereof
US8460697B2 (en) * 2006-12-13 2013-06-11 Susavion Biosciences, Inc. Pro-angiogenic peptides and uses thereof
US7838497B2 (en) * 2006-12-13 2010-11-23 Susavion Biosciences, Inc. Pro-angiogenic peptides
CN101391103B (zh) * 2008-07-31 2013-07-24 张可 一种预防和治疗艾滋病病毒感染的药物组合物
WO2010022227A1 (en) * 2008-08-20 2010-02-25 Schering Corporation Methods for monitoring il-10 therapy
WO2011047097A2 (en) * 2009-10-13 2011-04-21 Sigalov Alexander B Inhibition of trem receptor signaling with peptide variants
ES2600616T3 (es) * 2011-03-14 2017-02-10 Phlogo Aps Antagonistas del receptor de la interleucina-1
SG11201404850SA (en) 2012-02-13 2014-09-26 Agency Science Tech & Res IL-1β NEUTRALIZING HUMAN MONOCLONAL ANTIBODIES
WO2015009955A1 (en) 2013-07-18 2015-01-22 Xalud Therapeutics, Inc. Methods for the treatment of inflammatory joint disease
JP6140566B2 (ja) * 2013-07-31 2017-05-31 アイシン・エィ・ダブリュ株式会社 コイル装着方法及びコイル装着治具
CN105944086B (zh) * 2016-06-13 2017-08-25 浙江生创精准医疗科技有限公司 Il‑8单独或与其他细胞因子联合在治疗肝纤维化中的用途
EP4252629A3 (en) 2016-12-07 2023-12-27 Biora Therapeutics, Inc. Gastrointestinal tract detection methods, devices and systems
US11596670B2 (en) 2017-03-30 2023-03-07 Biora Therapeutics, Inc. Treatment of a disease of the gastrointestinal tract with IL-10 or an IL-10 agonist
US20220249814A1 (en) 2018-11-19 2022-08-11 Progenity, Inc. Methods and devices for treating a disease with biotherapeutics
US12352766B2 (en) * 2019-01-31 2025-07-08 Sekisui Medical Co., Ltd. Immunoassay method for free aim in biological sample, and method for detecting NASH in subject
EP4309722A3 (en) 2019-12-13 2024-08-07 Biora Therapeutics, Inc. Ingestible device for delivery of therapeutic agent to the gastrointestinal tract

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL94878A (en) * 1989-06-28 2003-01-12 Schering Corp Cytokine synthesis inhibitory factor, antagonists thereof and methods of using same
CA2115060C (en) * 1991-08-06 2003-05-06 Rene De Waal Malefyt Use of interleukin-10 analogs or antagonists to treat endotoxin- or superantigen induced toxicity
NZ249754A (en) * 1992-03-04 1997-06-24 Schering Corp Interleukin-10 and its use in inhibiting graft vs host disease or tissue rejection
CA2085291A1 (en) * 1992-07-30 1994-01-31 Martin L. Breitman Novel receptor tyrosine kinase
TW243415B (no) * 1992-08-20 1995-03-21 Schering Corp
CA2168110A1 (en) * 1993-07-26 1995-02-02 Chuan-Chu Chou Agonists and antagonists of human interleukin-10

Also Published As

Publication number Publication date
PL319429A1 (en) 1997-08-04
UA57702C2 (uk) 2003-07-15
ES2148525T3 (es) 2000-10-16
EE03451B1 (et) 2001-06-15
HU220344B (hu) 2001-12-28
RU2218348C2 (ru) 2003-12-10
PT769054E (pt) 2000-11-30
DE69518156T2 (de) 2001-01-11
DK0769054T3 (da) 2000-11-13
RO118758B1 (ro) 2003-10-30
HUT76673A (en) 1997-10-28
US6599501B1 (en) 2003-07-29
PL181042B1 (pl) 2001-05-31
CZ1497A3 (en) 1997-05-14
DE69518156D1 (de) 2000-08-31
US6159937A (en) 2000-12-12
EP0769054A1 (en) 1997-04-23
CN1216992C (zh) 2005-08-31
GR3034628T3 (en) 2001-01-31
US6168791B1 (en) 2001-01-02
NZ287406A (en) 1998-07-28
HK1012416A1 (en) 1999-07-30
CA2194444C (en) 2003-01-14
MX9606537A (es) 1997-12-31
HU9603615D0 (en) 1997-02-28
SK283096B6 (sk) 2003-02-04
FI970009L (fi) 1997-03-04
FI970009A7 (fi) 1997-03-04
CA2194444A1 (en) 1996-01-18
BR9508243A (pt) 1997-10-21
CN1159830A (zh) 1997-09-17
ATE195003T1 (de) 2000-08-15
AU686816B2 (en) 1998-02-12
EP0769054B1 (en) 2000-07-26
WO1996001318A1 (en) 1996-01-18
NO970020L (no) 1997-03-05
SK161496A3 (en) 1997-08-06
FI970009A0 (fi) 1997-01-02
EE9700029A (et) 1997-08-15
AP690A (en) 1998-10-16
EP1013764A1 (en) 2000-06-28
AP9700962A0 (en) 1997-04-30
JPH10502249A (ja) 1998-03-03
AU2612195A (en) 1996-01-25

Similar Documents

Publication Publication Date Title
DE69518156D1 (de) Immunomodulatoren
ATA166795A (de) Bis-resorcinyltriazine
ATA147195A (de) Alkoxyphenyl-substituierte bisbenzoylphosphinoxide
ATA163695A (de) 2-hydroxyphenyltriazine
BR9507091A (pt) Combinações insecticidamente ativas
ATA108995A (de) Differenzdruckakkumulator
ATA11894A (de) Stauförderbahn
FI1325U1 (fi) Snoebehandlingsanordning
IT243060Y1 (it) Infilacalze
ATE197372T1 (de) Vorteig
FI1652U1 (fi) Beredare-blandare
BR7400062U (pt) Prato-bandeja
BR9401008A (pt) Helistato
FIU940071U0 (fi) Schaktblad
BR7400053U (pt) T-compacto
BR9403990A (pt) Quandriciclo ciclo-car
BR9403759A (pt) Mastercalc
BR9403758A (pt) Multiplic
BR9403310A (pt) Regulex
BR9403309A (pt) Choppometro
SE9401660D0 (sv) Hyllbetjänt
ATA127394A (de) Holografischer neurochip
BR9403098A (pt) Turnimetro
BR9402584A (pt) Chavecheque
BR7400030U (pt) Numeralfa

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application